RAPIDLY-ACTING TREATMENTS FOR SEVERE TREATMENT RESISTANT DEPRESSION (RAPID)
RAPIDLY-ACTING TREATMENTS FOR SEVERE TREATMENT RESISTANT DEPRESSION (RAPID)
批准号:
9261423
负责人:
MAURIZIO FAVA
金额:
$176.83万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-12 至 2016-04-30
关键词:
AdultAgeAreaAuthorization documentationBudgetsClinicalClinical TrialsContractorContractsDevelopmentDiagnosisGovernmentGovernment ProgramsHourHumanInterventionIntramural Research ProgramMental DepressionNational Institute of Mental HealthProceduresRandomized Clinical TrialsSiteSleep DeprivationTestingantidepressant effectcohortcostefficacy trialmemberresponsetreatment-resistant depression
中文摘要
这一倡议所需的一般方法将是首先建立一个临床试验地点的小团队,然后在人体上测试已确定的干预措施(药理学和/或非药理学),进行足够强大的概念验证试验。试验将在团队成员(包括NIMH校内研究计划)确定有希望的干预措施并得到快速指导委员会和NIMH合同官员�S技术代表(有时也称为政府项目官员)的批准后开始。
如果根据本合同或在实地确定的任何化合物/干预措施被证明是有希望的,政府可以选择用该化合物/干预措施进行更大规模的疗效试验,而不是进行其他较小的概念验证试验(见任务4和5)。
以下列出的每个任务区域内的所有工作将由合同中更详细列出的任务订单程序控制。这些程序要求NIMH发出任务订单请求、承包商�S对请求的回应/建议(包括技术方法和预算),以及NIMH开始任务订单的最终批准。在任务单获得批准之前,不得产生或报销费用。核准的总费用是一个上限,未经进一步授权不得超过。
本合同的重点和目标是确定和测试最有希望的治疗难治性抑郁症的干预措施(无论是药理学的还是非药理学的)。
英文摘要
The general approach required for this initiative will be to first establish a small team of clinical trial sites and subsequently to test identified interventions (pharmacologic and/or non-pharmacologic) in adequately powered Proof of Concept trials in humans. Trials will be initiated after promising interventions are identified by members of the team (including the NIMH Intramural Research Program), and approved by the RAPID steering committee and the NIMH Contracting Officer�s Technical Representative (COTR) (sometimes also referred to as the Government Program Officer (GPO)).
If any compound/intervention identified under this contract or in the field proves to be promising, the Government may choose to conduct a larger efficacy trial with that compound/intervention in lieu of other smaller Proof of Concept trials (see Tasks 4 and 5).
All efforts within each task area outlined below will be controlled by task order procedures outlined in more detail in the contract. These procedures require the issuance of a task order request by NIMH, the Contractor�s response/proposal to a request (including a technical approach and budget), and final NIMH approval to begin the task order. Costs shall not be incurred or reimbursed until a task order has been approved. The approved total cost is a ceiling that cannot be exceeded without further authorization.
The emphasis and objective in this contract is to identify and test the most promising interventions for treatment resistant depression (either pharmacologic or non-pharmacologic).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2)
-
批准号:10818656
-
项目类别:
-
资助金额:$222.64万
-
财政年份:2021
-
负责人:MAURIZIO FAVA
-
依托单位:
EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2)
-
批准号:10267804
-
项目类别:
-
资助金额:$1301.6万
-
财政年份:2021
-
负责人:MAURIZIO FAVA
-
依托单位:
EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2)
-
批准号:10507014
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2021
-
负责人:MAURIZIO FAVA
-
依托单位:
RAPIDLY-ACTING TREATMENTS FOR TREATMENT-RESISTANT DEPRESSION (RAPID)
-
批准号:8947343
-
项目类别:
-
资助金额:$10.94万
-
财政年份:2014
-
负责人:MAURIZIO FAVA
-
依托单位:
1/2-Collaborative Study: Testosterone Antidepressant Augmentation in Women
-
批准号:8701405
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MAURIZIO FAVA
-
依托单位:
1/2-Collaborative Study: Testosterone Antidepressant Augmentation in Women
-
批准号:8582815
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MAURIZIO FAVA
-
依托单位:
1/2-Collaborative Study: Testosterone Antidepressant Augmentation in Women
-
批准号:8894609
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship and Training During Psychiatry Residency
-
批准号:10168709
-
项目类别:
-
资助金额:$1.51万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship and Training During Psychiatry Residency
-
批准号:8838861
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship & Training during Psychiatry Residency Supplement
-
批准号:10554804
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
RAPIDLY-ACTING TREATMENTS FOR TREATMENT-RESISTANT DEPRESSION (RAPID)
-
批准号:8340433
-
项目类别:
-
资助金额:$10.32万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship and Training During Psychiatry Residency
-
批准号:10166927
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship and Training During Psychiatry Residency
-
批准号:8178982
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship and Training During Psychiatry Residency
-
批准号:8265597
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship and Training During Psychiatry Residency
-
批准号:10399054
-
项目类别:
-
资助金额:$1.51万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship and Training During Psychiatry Residency
-
批准号:8649085
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
Fostering Research Mentorship and Training During Psychiatry Residency
-
批准号:8454511
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2011
-
负责人:MAURIZIO FAVA
-
依托单位:
3/3-Efficacy and Tolerability of Riluzole in Treatment-Resistant Depression
-
批准号:7884843
-
项目类别:
-
资助金额:$24.55万
-
财政年份:2010
-
负责人:MAURIZIO FAVA
-
依托单位:
3/3-Efficacy and Tolerability of Riluzole in Treatment-Resistant Depression
-
批准号:8463245
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2010
-
负责人:MAURIZIO FAVA
-
依托单位:
3/3-Efficacy and Tolerability of Riluzole in Treatment-Resistant Depression
-
批准号:8269775
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2010
-
负责人:MAURIZIO FAVA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: